Skip to main content
Premium Trial:

Request an Annual Quote

Sophia Genetics's BRCA Tumor MASTR Plus and SOMATIC 1 MASTR Plus

Sophia Genetics has launched two new applications, BRCA Tumor MASTR Plus kit and SOMATIC 1 MASTR Plus kit. Both next-generation sequencing kits are available on Sophia DDM, the company's genomics platform, and have been given the CE-IVD mark. BRCA Tumor MASTR Plus diagnoses breast and ovarian cancers. SOMATIC 1 MASTR Plus diagnoses colorectal cancers, pancreatic cancer, thyroid follicular tumours, melanoma, and myeloid disorders.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.